<DOC>
	<DOC>NCT00655109</DOC>
	<brief_summary>To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis</brief_summary>
	<brief_title>A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis</brief_title>
	<detailed_description>Study will evaluate the efficacy of nasal anti-allergic therapy compared to ocular anti-allergic therapy in the prevention of ocular allergic symptoms.</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>At least 18 years of age &amp; either sex, any race Willing and able to follow all instructions and attend all study visits Positive history of ocular allergies Reproducible positive ocular allergic reaction induced by conjunctival allergen challenge Have planned surgery during trial period Female currently pregnant, planning a pregnancy, or lactating Use of disallowed medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
	<keyword>Allergic rhinoconjunctivitis</keyword>
</DOC>